Clinical Trials
4 trialsNCT01083368 2019-08-21
Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy
Case Comprehensive Cancer Center
Phase 1/2 Completed
NCT01026623 2019-06-17
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT01206036 2016-01-27
CEPTAS
Central European Society for Anticancer Drug Research
Phase 1/2 Completed
NCT01020305 2014-10-13
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
Stanford University
Phase 1/2 Terminated